Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy-Reference-Cited by-同舟云学术

Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy

Published:2007-10 Issue:4 Volume:178 Page:1290-1295
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Morote Juan¹,Orsola Anna¹,Planas Jacques¹,Trilla Enrique¹,Raventós Carles X.¹,Cecchini Lluís¹,Catalán Roberto¹

Affiliation:

1. Department of Urology, Vall d’Hebron Hospital and Autonoma University of Barcelona School of Medicine, Barcelona, Spain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Studies on prostate cancer: the effect of castration, estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Role of luteinising hormone releasing hormone (LHRH) agonist in the management of prostate cancer;Mongiat-Artus;Eur Urol,2005

3. Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology and clinical studies;Schally;Fertil Steril,1971

4. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma;Kaisary;Br J Urol,1991

5. Leuprolide versus diethylstilbestrol for metastatic prostate cancer;N Engl J Med,1984

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles of castration resistant prostate cancer;Revisiones en Cáncer;2024

2. Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review;Cancers;2023-07-03

3. Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy;The Prostate;2023-02-27

4. Serum testosterone measured by liquid chromatography-tandem mass spectrometry is an independent predictor of response to castration in metastatic hormone-sensitive prostate cancer;Clinica Chimica Acta;2023-01

5. Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review;Therapeutic Advances in Medical Oncology;2023-01